Phase 3 Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with colon cancer and scans suggest it may have spread to nearby lymph nodes in the abdomen before your main surgery
- You have colon cancer that has spread to other parts of the body, but doctors believe it could potentially be treated or removed
- Your scans or a blood test result (called CEA, a marker sometimes linked to cancer) suggest the cancer may have come back or spread after previous treatment
- You are generally able to carry out daily activities, with little to no limitation from your illness (confirm with trial site)
- You are willing to sign a consent form after being given written information about the study
Who may not be able to join:
- You belong to a group protected under Finnish law on clinical studies, including people with certain disabilities, children, pregnant women, breastfeeding women, or prisoners
- You are unable to understand what the study involves or what it is for
- You have a health condition that means you cannot safely have a full-body PET-CT scan (a type of imaging scan — confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Saila Kauhanen, Turku PET Centre, Turku University Hospital
Phone: +358503017010
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
1) To assess the sensitivity and specificity of 18F-FAPI-74 PET/CT in detection of local lymph node metastasis in patient level in patients with primary colon cancer; 2) To assess the sensitivity and specificity of 18F-FAPI-74 PET/CT in detection of distant metastasis in patient level in patients with primary colon cancer; 3) To assess the sensitivity and specificity of 18F-FAPI-74 PET/CT in detection of local lymph metastasis and distant metastasis in patient level in patients with recurrent colon cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.